Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study

Citation metadata

From: Clinical Drug Investigation(Vol. 35, Issue 3)
Publisher: Wolters Kluwer Health, Inc.
Document Type: Report

Document controls

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A406034576